scholarly journals Clinical utility of tumor marker cutoff ratio and a combination scoring system of preoperative carcinoembryonic antigen, carbohydrate antigen 19-9, carbohydrate antigen 72-4 levels in gastric cancer

2013 ◽  
Vol 85 (6) ◽  
pp. 283 ◽  
Author(s):  
Jong-Chan Lee ◽  
Se Youl Lee ◽  
Chan Young Kim ◽  
Doo Hyun Yang
2013 ◽  
Vol 24 ◽  
pp. iv56
Author(s):  
Fatima Zahra Hijri ◽  
Adil Najdi ◽  
Samia Arifi ◽  
Nawfel Mellas ◽  
Mohamed Amine Berraho ◽  
...  

1999 ◽  
Vol 23 (2) ◽  
pp. 116-122 ◽  
Author(s):  
Giuseppe Esposito ◽  
Alfonso Tempesta ◽  
Maria Giulia Galati ◽  
Mario de Bellis ◽  
Giovanni Battista Rossi ◽  
...  

2015 ◽  
Vol 30 (3) ◽  
pp. 259 ◽  
Author(s):  
Jaihwan Kim ◽  
Yoon Suk Lee ◽  
In Kyeom Hwang ◽  
Bong Kyun Kang ◽  
Jai Young Cho ◽  
...  

1986 ◽  
Vol 19 (12) ◽  
pp. 2421-2423 ◽  
Author(s):  
Yutaka TAKAHASHI ◽  
Masayoshi MAI ◽  
Tomomi OGINO ◽  
Hiroshi UEDA ◽  
Tokuji KITAMURA ◽  
...  

2018 ◽  
Vol 6 (4) ◽  
pp. 179-185
Author(s):  
Rasoul Estakhri ◽  
Kourosh Masnadi Shirazi ◽  
Morteza Ghojazadeh ◽  
Gilda Ghazisoltani ◽  
Mahzad Azimpouran ◽  
...  

Introduction: Gastric cancer is a rather common malignancy worldwide and a major healthcare system issue. Lately, the importance of biomarkers such as macrophage migration inhibitory factor (MIF) has been demonstrated in the diagnosis of various gastrointestinal (GI) malignancies. The present study aimed to evaluate the diagnostic value of MIF, carcinoembryonic antigen (CEA), and carbohydrate antigen 19-9 (CA 19-9) in gastric cancer. Methods: In this descriptive-analytical study, 84 patients with gastric cancer referred to the gastroenterology clinic of Tabriz University of Medical Sciences, Tabriz, Iran, for diagnostic and therapeutic procedures, and 80 healthy individuals were enrolled. Serum levels of MIF, CEA, and CA 19-9 were measured in both groups. Further, the grade and stage of the cancer were determined in in the patient group. Results: Serum levels of all three MIF, CEA, and CA 19-9 biomarkers in patients with gastric cancer were significantly higher than those of the control group (P = 0.001). However, no statistically significant correlations were found between the studied biomarkers with the tumor grade and stage. The MIF cut-off point for the diagnosis of gastric cancer was found to be 7.05 pg/ml and its sensitivity and specificity were 85.7% and 73.8%, respectively. Conclusion: MIF biomarker may involve in the pathogenesis and development of gastric cancer and it is a potential diagnostic and therapeutic marker in this malignancy.


Surgery Today ◽  
2016 ◽  
Vol 47 (2) ◽  
pp. 227-232 ◽  
Author(s):  
Noriko Wada ◽  
Yukinori Kurokawa ◽  
Yasuhiro Miyazaki ◽  
Tomoki Makino ◽  
Tsuyoshi Takahashi ◽  
...  

2001 ◽  
Vol 32 (1) ◽  
pp. 41-44 ◽  
Author(s):  
Sumiya Ishigami ◽  
Shoji Natsugoe ◽  
Shuuichi Hokita ◽  
Xiangming Che ◽  
Kohki Tokuda ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document